Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1352 Views
-
Last post by frodo
-
- 0 Replies
- 990 Views
-
Last post by frodo
-
- 0 Replies
- 2306 Views
-
Last post by NHE
-
- 0 Replies
- 1280 Views
-
Last post by frodo
-
- 0 Replies
- 1252 Views
-
Last post by frodo
-
- 0 Replies
- 1221 Views
-
Last post by frodo
-
- 0 Replies
- 1493 Views
-
Last post by NHE
-
- 0 Replies
- 473 Views
-
Last post by NHE
-
- 1 Replies
- 2934 Views
-
Last post by Tif